Compositions and methods for joining non-conjoined lumens

• US 8,172,861 B2
• Filed: 12/19/2008
• Issued: 05/08/2012
• Est. Priority Date: 12/20/2007
• Status: Active Grant

• Current Assignee: Tautona Group LP
• Original Assignee: Tautona Group LP
• Inventors: Fuller, Gerald G., Rappleye, C. Travis, Mandrusov, Evgenia
• Primary Examiner(s): Woo, Julian
• Application Number:
  US12/340,586
• Publication Number:
  US 20090162438A1
• Time in Patent Office: 1,236 Days
• Field of Search: 606/214, 606/213, 606/153, 606/155, 424/422, 424/423, 424/426, 424/427, 424/428, 424/484, 424/486, 514/20.8, 623/1.1
• US Class Current: 606/153
• CPC Class Codes: A61L 27/14 Macromolecular materials

Abstract

Sol-gel compositions, methods, and kits for joining together non-conjoined lumens in a patient'"'"'s body including vascular lumens. More particularly, in various aspects, this invention provides thermoreversible sol-gel compositions, methods, and kits for joining such non-conjoined lumens, including small lumens typically requiring microsurgical technique.

Claims

1. A thermoreversible sol-gel composition for surgical use having a phase transition temperature from a liquid phase to a gel phase of at least 1°

C. above or below the temperature of the surgical field and a gel phase elastic modulus of at least 8,000 Pascals, which composition comprises

a) about 25 to 33% of a mixture of poloxamer 407 and poloxamer 188 in a ratio of between 3;

1 and 0.8;

1; and

b) an aqueous salt solution having an ionic strength of from about 0.05 M to about 0.4 M.

2. The composition of claim 1, wherein the transition temperature is at least 3°

C. above or below the temperature of the surgical field.

3. The composition of claim 1, which composition is sterile.

4. The composition of claim 1, wherein the phase transition temperature is about 33 to 38°

C.

5. The composition of claim 1, wherein the elastic modulus of the gel phase is at least 10,000 Pascals.

6. The composition of claim 1, which composition has a pH of about 6 to 8.

7. The composition of claim 1, comprising about 27 to 29% of a mixture of poloxamer 407 and poloxamer 188 in a ratio of between 1.5:

1 and 1.6;

1.

8. The composition of claim 1, wherein the salt is selected from the group consisting of sodium chloride, potassium chloride, sodium sulfate, sodium bisulfate, sodium phosphate, monosodium phosphate, disodium phosphate, potassium phosphate, monopotassium phosphate, dipotassium phosphate, calcium chloride, magnesium chloride, and a combination thereof.

9. The composition of claim 1, wherein the aqueous salt solution is phosphate buffered saline.

10. The composition of claim 1, comprising

about 17% w/w of poloxamer 407;

about 11% w/w of poloxamer 188;

and about 72% of phosphate buffered saline solution.

11. The composition of claim 1, further comprises a biologically active agent, a biocompatible dye, or a biocompatible contrasting agent or combinations thereof.

12. The composition of claim 11, wherein the biologically active agent is selected from the group consisting of an anti-coagulant, anti-spasm agents, anti-restenosis agents, pro-angiogenic agents, fibroblast growth factor, insulin-like growth factor, vascular endothelial growth factor, hepatocyte growth factor, monocyte chemotactic protein-1, nitroglycerine, everolimus, sirolimus, paclitaxel, rapamycin, biolimus, and combinations thereof, and further wherein the biologically active agent is optionally formulated in sustained release or in gene vectors.

13. The composition of claim 12, wherein the biologically active agent is heparin.

14. A method for joining at least two non-conjoined lumens in a patient which method comprises:

(a) applying a composition of claim 1 by injection with a hypodermic needle and/or a syringe in at least the distal portion of at least one of the lumens in a manner which imparts structural integrity to said portion of the lumen;

(b) aligning the lumens;

(c) joining the aligned lumens to form a conduit; and

(d) removing the composition thereby establishing body fluid flow through the conduit.

15. The method of claim 14, wherein the lumens are joined by applying a biocompatible adhesive between an end of the first lumen and an end of the second lumen and allowing the adhesive to form bonds between the lumens.

16. The method of claim 15, wherein the biocompatible adhesive is selected from among a cyanoacrylate-based adhesive, a fibrin-based adhesive, a polyurethane-based adhesive, a latex glue, a biologics glue, a polyethylene glycol-based glue, and a polyisocyanate-based adhesive.

17. The method of claim 15, wherein the adhesive is applied to the cross-sectional surfaces of the lumens.

18. The method of claim 15, wherein the adhesive is applied around the circumference of the joined lumens.

19. The method of claim 15, wherein the adhesive further forms an external stent.

20. The method of claim 14, wherein the lumens are joined by a method comprising sutures, electrocautery, or applying laser.

21. The method of claim 14, further comprising an extra step of partially suturing the lumens, where the extra step is performed before and/or after step (a).

22. A method for joining at least two non-conjoined lumens in a patient, wherein at least one of the lumens has a clamp to arrest the flow of the fluid therein, which method comprises:

(a) providing a thermoreversible sol-gel composition of claim 1 by injection with a hypodermic needle and/or a syringe in a gel phase in at least the distal portion of at least one of the lumens in a manner which imparts structural integrity to said portion of the lumen;

(b) aligning the lumens;

(c) closing the aligned lumens to form a conduit;

(d) inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase;

(e) confirming substantial completion of the phase transition; and

(f) removing the clamp(s) thereby establishing flow through the conduit.

23. A method for joining at least two non-conjoined lumens in a patient, which method comprises:

(a) approximating the lumens in a connecting position;

(b) providing a thermoreversible sol-gel composition of claim 1 by injection with a hypodermic needle and/or a syringe in a gel phase in the distal portion of both lumens in a manner which imparts structural integrity to said portion of the lumen;

(c) closing the lumens to form a conduit;

(d) inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase; and

(e) establishing flow through the conduit.

24. A method for joining at least two non-conjoined lumens in a patient, wherein at least one of the lumens is clamped to arrest the flow of body fluid therein, which method comprises:

flushing the distal potion of the clamped lumen with a biocompatible liquid;

approximating the lumens in a connecting position, which approximating comprises partially suturing the lumens;

providing a thermoreversible sol-gel composition of claim 1 by injection with a hypodermic needle and/or a syringe in a gel phase in the distal portion of both lumens in a manner which imparts structural integrity to said portion of the lumen;

closing the lumens to form a conduit with a biocompatible adhesive;

inducing a phase transition of the sol-gel wherein the sol-gel changes from the gel phase to a liquid phase;

confirming substantial completion of the phase transition; and

removing the clamps thereby establishing flow through the conduit and removing the sol-gel composition.

25. The method of claim 14 or 24, wherein a first lumen is a vessel of the cardiovascular system of a human.

26. The method of claim 25, wherein a second lumen is selected from the group consisting of a vessel of the cardiovascular system of a human, an arteriovenous graft, an allograft, a xenograft, cadaver xenograft, a synthetic graft, and an arteriovenous shunt.

27. The method of claim 14 or 24, wherein at least one of the lumens has a diameter of less than 1 mm.

28. The method of claim 14 or 24, wherein the at least two lumens are selected from the group consisting of human fallopian tubes, vas deferens, tubes in the alimentary canal, pancreatic ducts, bile ducts, tear ducts, and mammary ducts.

29. The method of claim 14 or 24, wherein the lumens are joined end to end, end to side or side to side.

30. A kit for connecting at least two non-conjoined lumens within a living mammal, comprising:

a delivering device; and

a composition of claim 1.

31. The kit of claim 30, wherein the delivering device is a syringe.

32. The kit of claim 31, wherein the composition is loaded in the syringe.

33. The kit of claim 30, where delivery device is a catheter or a laparoscopic tool.

34. The kit of claim 30, wherein the delivery device is coupled with a heating or cooling component.

35. The kit of claim 30, further comprising at least one clamp for arresting the flow of body fluid in at least one of the non-conjoined lumen, a biocompatible adhesive for sealing the lumens or a heat source.

36. A method for imaging the geometry of the distal portion of at least one lumen being supported by a sol-gel composition of claim 1 and the joinder of the lumen with at least another lumen in a patient, wherein the sol-gel composition is provided to the lumen by injection with a hypodermic needle and/or a syringe.

37. A method for visualizing guidance of the geometry of the distal portion of at least one lumen being supported by a sol-gel composition of claim 1 and the joinder of the lumen with at least another lumen in a patient, wherein the sol-gel composition is provided to the lumen by injection with a hypodermic needle and/or a syringe.

38. A method for evaluating the effectiveness of a method for joining at least two non-conjoined lumens in a patient wherein at least one of the non-conjoined lumens has a sol-gel composition of claim 1 to provide geometry support for the lumen, wherein the sol-gel composition is provided to the lumen by injection with a hypodermic needle and/or a syringe.